DCPH - Deciphera Pharmaceuticals Inc. (DCPH) CEO Steven Hoerter on Q4 2020 Results - Earnings Call Transcript
Deciphera Pharmaceuticals, Inc. (DCPH) Q4 2020 Earnings Conference Call February 09, 2021, 16:30 PM ET Company Participants Jen Robinson - Vice President, Investor Relations Steven Hoerter - President and Chief Executive Officer Daniel Martin - Chief Commercial Officer Matthew Sherman - Chief Medical Officer Tucker Kelly - Executive Vice President and Chief Financial Officer Conference Call Participants Jessica Fye - JPMorgan Allison Bratzel - Piper Sandler Michael Schmidt - Guggenheim Eun Yang - Jefferies Andrew Berens - SVB Leerink Peter Lawson - Barclays Reni Benjamin - JMP Securities Robyn Karnauskas - Truist Presentation Operator Good afternoon, everyone, and welcome to the Deciphera Pharmaceuticals Fourth Quarter and Full Year 2020 Financial Results Conference Call. Today's call is being recorded. At this time, I would now like to turn the call over to Jen Robinson, Vice President, Investor Relations. Jen? Jen Robinson Welcome and thank you for joining us today to discuss
For further details see:
Deciphera Pharmaceuticals, Inc. (DCPH) CEO Steven Hoerter on Q4 2020 Results - Earnings Call Transcript